Physician profile
Tyler Ray Freeman
NPI 1881199644
$12,046.03
in general payments reported to CMS, 2019-2025
11 companies · $984 in 2025
The $984 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,400 · 2023: $4,059 · 2024: $4,603 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,333 · Grant: $3,333 · Food and Beverage: $2,239 · Travel and Lodging: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,333.33 |
| Grant | $3,333.33 |
| Food and Beverage | $2,238.90 |
| Travel and Lodging | $740.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,004.80 | 2023-2025 | Evos Mini, Maverick, Real Intelligence |
| Gemini Mountain Medical, LLC | $2,400.00 | 2022 | |
| Stryker Corporation | $1,739.00 | 2023-2025 | Mako, Gamma, Axsos |
| Depuy Synthes Sales INC. | $420.65 | 2025 | Tfn-Advance |
| Heron Therapeutics, INC. | $121.84 | 2025 | Zynrelef |
| Skeletal Dynamics INC | $120.00 | 2024 | Align, Implate, Ijs |
| Globus Medical, INC. | $93.29 | 2024-2025 | Autobahn, Anthem, Stretto |
| Bioventus LLC | $58.53 | 2024 | Durolane |
| Medacta USA, INC. | $46.11 | 2025 | Gmk Sphere |
| Pacira Pharmaceuticals Incorporated | $25.37 | 2025 | Exparel |
| Alafair Biosciences, INC. | $16.44 | 2025 | Versawrap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.